Identification of Natural Compounds with Antiviral Activities Against SARS-associated Coronavirus

Overview

Journal Antiviral Res

Publisher Elsevier

Date 2005 May 12

PMID 15885816

Citations 252

Authors

Shi-You Li

Cong Chen

Hai-Qing Zhang

Hai-Yan Guo

Hui Wang

Lin Wang

Xiang Zhang

Shi-Neng Hua

Jun Yu

Pei-Gen Xiao

Rong-Song Li

Xuehai Tan

Affiliations

Soon will be listed here.

Abstract

More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for virus-induced cytopathic effect (CPE). Four of these extracts showed moderate to potent antiviral activities against SARS-CoV with 50% effective concentration (EC50) ranging from 2.4 +/- 0.2 to 88.2 +/- 7.7 microg/ml. Out of the four, Lycoris radiata was most potent. To identify the active component, L. radiata extract was subjected to further fractionation, purification, and CPE/MTS assays. This process led to the identification of a single substance lycorine as an anti-SARS-CoV component with an EC50 value of 15.7 +/- 1.2 nM. This compound has a CC50 value of 14980.0 +/- 912.0 nM in cytotoxicity assay and a selective index (SI) greater than 900. The results suggested that four herbal extracts and the compound lycorine are candidates for the development of new anti-SARS-CoV drugs in the treatment of SARS.

Citing Articles

Antiviral alkaloids from : Extraction, synergistic effects, and activity against dengue virus and human coronavirus OC43.

Jayawardena T, Merindol N, Liyanage N, Gelinas S, Lionel B, Seydou K Heliyon. 2025; 11(4):e42580.

PMID: 40028517 PMC: 11870263. DOI: 10.1016/j.heliyon.2025.e42580.

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.

Latarissa I, Khairinisa M, Iftinan G, Meiliana A, Sormin I, Barliana M Clin Pharmacol. 2025; 17():1-11.

PMID: 39845335 PMC: 11748038. DOI: 10.2147/CPAA.S493750.

Phytochemical and Cytotoxic Aspects of Amaryllidaceae Alkaloids in Species: A Review.

Georgiev B, Sidjimova B, Berkov S Plants (Basel). 2025; 13(24.

PMID: 39771275 PMC: 11678157. DOI: 10.3390/plants13243577.

Plant resources for immunonutrients and immunomodulators to combat infectious respiratory viral diseases: a review.

Kota S, Nelapati A, Govada V 3 Biotech. 2024; 14(12):302.

PMID: 39554986 PMC: 11568085. DOI: 10.1007/s13205-024-04143-y.

Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway.

Cao Z, Ma N, Shan M, Wang S, Du J, Cheng J Int J Mol Sci. 2024; 25(18).

PMID: 39337417 PMC: 11431997. DOI: 10.3390/ijms25189930.

References

Tsang K, Ho P, Ooi G, Yee W, Wang T, Chan-Yeung M . A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20):1977-85. DOI: 10.1056/NEJMoa030666. View

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

Chan-Yeung M, Yu W . Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report. BMJ. 2003; 326(7394):850-2. PMC: 153470. DOI: 10.1136/bmj.326.7394.850. View

Jassim S, Naji M . Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. 2003; 95(3):412-27. DOI: 10.1046/j.1365-2672.2003.02026.x. View

Hung S, Ma G . [STUDIES ON THE ALKALOIDS OF AMARYLLIDACEAE. III. THE ALKALOIDS OF LYCORIS SQUAMIGERA MAXIM. AND OTHER 2 LYCORIS SPECIES, AND A NEW ALKALOID, SQUAMIGERINE]. Yao Xue Xue Bao. 1964; 11:1-14. View

Kim T, Imakura Y, Kihara M, Kobayashi S . Effect of alkaloids isolated from Amaryllidaceae on herpes simplex virus. Res Virol. 1989; 140(2):115-28. DOI: 10.1016/s0923-2516(89)80089-5. View

Ieven M, Vlietinck A, Vanden Berghe D, Totte J, Dommisse R, Esmans E . Plant antiviral agents. III. Isolation of alkaloids from Clivia miniata Regel (Amaryllidaceae). J Nat Prod. 1982; 45(5):564-73. DOI: 10.1021/np50023a009. View

Vlietinck A, Vanden Berghe D . Can ethnopharmacology contribute to the development of antiviral drugs?. J Ethnopharmacol. 1991; 32(1-3):141-53. DOI: 10.1016/0378-8741(91)90112-q. View

Zhao C, Guo Y, Wu H, Li X, Guo X, Jin R . [Clinical manifestation, treatment, and outcome of severe acute respiratory syndrome: analysis of 108 cases in Beijing]. Zhonghua Yi Xue Za Zhi. 2003; 83(11):897-901. View

10.

Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H . Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003; 361(9374):2045-6. PMC: 7112442. DOI: 10.1016/s0140-6736(03)13615-x. View

11.

Lin L, Han Y, Yang Z . [Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003; 23(6):409-13. View

12.

Cortese I, Renna G, Siro-Brigiani G, Poli G, Cagiano R . [Pharmacology of lycorine. 1) Effect on biliary secretion in the rat]. Boll Soc Ital Biol Sper. 1983; 59(9):1261-4. View

13.

Xiao Z, Li Y, Chen R, Li S, Zhong S, Zhong N . A retrospective study of 78 patients with severe acute respiratory syndrome. Chin Med J (Engl). 2003; 116(6):805-10. View

14.

Takagi S, KATAGI T, Takebayashi K . Gas liquid chromatography of alkaloids. II. Quantitative analysis of alkaloids of Lycoris radiata herb. Chem Pharm Bull (Tokyo). 1968; 16(6):1121-3. DOI: 10.1248/cpb.16.1121. View

15.

Zhong N, Zeng G . Our strategies for fighting severe acute respiratory syndrome (SARS). Am J Respir Crit Care Med. 2003; 168(1):7-9. DOI: 10.1164/rccm.200305-707OE. View

16.

Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt G . A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20):1986-94. DOI: 10.1056/NEJMoa030685. View

17.

Peiris J, Chu C, Cheng V, Chan K, Hung I, Poon L . Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003; 361(9371):1767-72. PMC: 7112410. DOI: 10.1016/s0140-6736(03)13412-5. View

18.

Cory A, Owen T, BARLTROP J, CORY J . Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991; 3(7):207-12. DOI: 10.3727/095535491820873191. View

19.

Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H . Treatment of SARS with human interferons. Lancet. 2003; 362(9380):293-4. PMC: 7112413. DOI: 10.1016/s0140-6736(03)13973-6. View

20.

Wu C, Jan J, Ma S, Kuo C, Juan H, Cheng Y . Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A. 2004; 101(27):10012-7. PMC: 454157. DOI: 10.1073/pnas.0403596101. View